Comparing ibrutinib efficacy and toxicity levels by age for patients with CLL/SLL
Predicting and diagnosing TB and CMV in hematopoietic cell transplant recipients
Current research to overcome T-cell dysfunction in CLL and improve therapies
Understanding the drivers behind disease with the 100,000 Genomes Project
Venetoclax in combination with ibrutinib: can it control CLL?